CRISPR-Edited Immune Effectors: The End of the Beginning.
Molecular therapy : the journal of the American Society of Gene Therapy, 28(4): 995-996 PMID 32203679 DOI 10.1016/j.ymthe.2020.03.009
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.